[Form 4] Tivic Health Systems, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lisa G. Wolf, Chief Financial Officer of Tivic Health Systems, Inc. (TIVC), was granted 80,000 employee stock options on 08/06/2025. The options have an exercise price of $3.32 and expire on 08/05/2035. The filing shows the options were acquired (reported as an award) and are held directly by the reporting person, with 80,000 derivative securities beneficially owned following the transaction. The grant vests 50% on the first anniversary of the grant and the remaining 50% in twelve equal quarterly installments, such that the award is fully vested on the fourth anniversary.

Positive

• 80,000 employee stock options granted to Lisa G. Wolf (CFO) recorded on 08/06/2025.
• Exercise price $3.32 with a defined vesting schedule and expiration 08/05/2035, providing clear terms.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine executive option grant increasing CFO's direct holdings by 80,000 options at a $3.32 strike.

The Form 4 documents a standard equity compensation event: an 80,000 employee stock option award to the CFO recorded on 08/06/2025 with a $3.32 exercise price and an 08/05/2035 expiration. The post-transaction beneficial ownership reported is 80,000 derivative securities held directly. This is a compensation-related issuance rather than a market sale or purchase, and the vesting schedule (50% at one year, remainder over 12 quarterly installments) clarifies when economic interest vests.

Corporate Governance Expert

TL;DR: Award follows a typical multi-year vesting schedule and was timely disclosed on Form 4.

The record includes a clear vesting timeline and ten-year contractual life (expiration 08/05/2035), consistent with common executive option grants. Reporting identifies Lisa G. Wolf as the reporting person and Chief Financial Officer and indicates direct ownership of the derivative securities after the grant. The Form 4 shows compliance with Section 16 reporting for insider awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wolf Lisa G

(Last) (First) (Middle)

47685 LAKEVIEW BLVD.

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tivic Health Systems, Inc. [ TIVC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Purchase)	$3.32	08/06/2025		A		80,000		(1)	08/05/2035	Common Stock	80,000	$0.00	80,000	D

Explanation of Responses:

1. The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date.

	/s/ Jennifer Ernst, attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Tivic Health (TIVC) disclose in the Form 4 filed by its CFO?

The Form 4 reports that Lisa G. Wolf, Chief Financial Officer, was granted 80,000 employee stock options on 08/06/2025.

How many options were granted and what is the exercise price (TIVC)?

The filing shows 80,000 options with an exercise price of $3.32.

What is the vesting schedule for the options reported on Form 4 (TIVC)?

The options vest 50% on the first anniversary of the grant and the remaining 50% in twelve equal quarterly installments, reaching 100% vesting at the fourth anniversary.

When do the options expire according to the Form 4 for TIVC?

The options have an expiration date of 08/05/2035.

Does the Form 4 show direct or indirect ownership after the transaction (TIVC)?

The Form 4 reports the ownership form as Direct (D), with 80,000 derivative securities beneficially owned following the transaction.